Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

463
Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
463
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

358
Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
358
Hypertension V: Nursing Management01:23

Hypertension V: Nursing Management

268
The nursing management of hypertension involves accurately assessing symptoms, making a comprehensive nursing diagnosis, collaborating with patients to set goals, and implementing targeted interventions to mitigate the condition's impact and improve patient well-being.Comprehensive AssessmentThe initial step in nursing care for hypertension involves a thorough patient assessment. It includes evaluating symptoms such as headaches, dizziness, blurred vision, and previous hypertension episodes.
268
Hypertension I: Introduction01:28

Hypertension I: Introduction

556
Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
556
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

599
Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
599
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

796
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
796

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Artificial intelligence for sexual, reproductive and maternal health in Latin America and the Caribbean: a scoping review.

Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology·2026
Same author

Hantavirus: the need for a rapid regional response platform in Latin America.

Lancet (London, England)·2026
Same author

Examining women's choice between home and institutional births: Insights from the Salud Mesoamérica Initiative (SMI).

PloS one·2026
Same author

Integrating systems thinking with global implementation science to co-learn and co-create mental health interventions and strategies with Maya Indigenous community partners.

The Lancet. Global health·2026
Same author

Experiences and impact of Duelo Migratorio among Venezuelan refugees and migrants in Peru: characterizing a cultural construct of distress.

Conflict and health·2025
Same author

Body Mass Index and Bronchodilator Responsiveness in Adults: Analysis of 2 Population-Based Studies in 4 South American Countries.

Chronic obstructive pulmonary diseases (Miami, Fla.)·2025

Related Experiment Video

Updated: Dec 18, 2025

Visualizing Field Data Collection Procedures of Exposure and Biomarker Assessments for the Household Air Pollution Intervention Network Trial in India
09:33

Visualizing Field Data Collection Procedures of Exposure and Biomarker Assessments for the Household Air Pollution Intervention Network Trial in India

Published on: December 23, 2022

2.6K

Evaluating a multicomponent program to improve hypertension control in Guatemala: study protocol for an

Alejandra Paniagua-Avila1,2, Meredith P Fort2,3, Russell E Glasgow4

  • 1Mailman School of Public Health, Columbia University, New York, NY, USA.

Trials
|June 11, 2020
PubMed
Summary
This summary is machine-generated.

This study evaluates a multilevel hypertension control program in Guatemala to improve blood pressure management in low-income countries. Findings will inform strategies for effective, sustainable hypertension interventions.

Keywords:
Cardiovascular diseaseGuatemalaHealth systemsHypertensionImplementation scienceImplementation strategiesLow-income and middle-income countriesMulticomponent programNon-communicable diseasesPrimary care

More Related Videos

A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program
04:24

A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program

Published on: April 19, 2019

12.1K
Multidisciplinary Approach to Obesity Management: A Case Report
05:10

Multidisciplinary Approach to Obesity Management: A Case Report

Published on: May 30, 2025

785

Related Experiment Videos

Last Updated: Dec 18, 2025

Visualizing Field Data Collection Procedures of Exposure and Biomarker Assessments for the Household Air Pollution Intervention Network Trial in India
09:33

Visualizing Field Data Collection Procedures of Exposure and Biomarker Assessments for the Household Air Pollution Intervention Network Trial in India

Published on: December 23, 2022

2.6K
A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program
04:24

A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program

Published on: April 19, 2019

12.1K
Multidisciplinary Approach to Obesity Management: A Case Report
05:10

Multidisciplinary Approach to Obesity Management: A Case Report

Published on: May 30, 2025

785

Area of Science:

  • Public Health
  • Cardiovascular Medicine
  • Implementation Science

Background:

  • Hypertension is a significant risk factor for cardiovascular disease (CVD).
  • Effective hypertension control remains low, especially in low- and middle-income countries (LMICs).
  • A proven multilevel, multicomponent program from Argentina is adapted for evaluation in Guatemala.

Purpose of the Study:

  • To evaluate the clinical effectiveness and implementation of an adapted multilevel hypertension control program in Guatemala.
  • To assess improvements in hypertension awareness, treatment, and control rates.
  • To generate data on scalable and sustainable interventions for LMICs.

Main Methods:

  • Hybrid type 2 effectiveness-implementation design over 18 months.
  • Cluster randomized trial assigning 36 health districts (18 intervention, 18 usual care), enrolling 1584 participants.
  • Mixed-methods approach using the RE-AIM/PRISM framework to assess clinical and implementation outcomes (e.g., reach, adoption, fidelity, sustainability, cost-effectiveness).

Main Results:

  • Clinical outcomes include the proportion of patients with controlled hypertension (<130/80 mmHg) and net change in blood pressure.
  • Implementation outcomes encompass acceptability, adoption, feasibility, fidelity, adaptation, reach, sustainability, and cost-effectiveness.
  • The study will provide data on the program's impact on patient, provider, and health system levels.

Conclusions:

  • Dissemination of findings to promote program scale-up and scale-out.
  • Generation of evidence for effective, adoptable, and sustainable hypertension control strategies.
  • Contribution to improving hypertension control in Guatemala and other LMICs.